SeLux Diagnostics, Inc.

Biotechnology company · Charlestown, Massachusetts, United States

SeLux Diagnostics, Inc. is a biotechnology company headquartered in Charlestown, Massachusetts, United States. Its earliest recorded incorporation is in 2014. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $5.1 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $40 million sold in a notice filed in 2024.

www.seluxdx.comProfile compiled from public records. Is this your company? Request a correction or update

SeLux Diagnostics at a glance

Typebiotechnology company
HeadquartersCharlestown, Massachusetts, United States
Earliest incorporation on record2014
Employees (self-reported, 2021)5
SEC CIK1736293

What does SeLux Diagnostics do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $5.1 million in total (2016 to 2021). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development.

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $40 million sold (2024).

Frequently asked questions about SeLux Diagnostics

Where is SeLux Diagnostics headquartered?

SeLux Diagnostics, Inc. is headquartered in Charlestown, Massachusetts, United States.

What does SeLux Diagnostics do?

SeLux Diagnostics, Inc. is a biotechnology company.

When was SeLux Diagnostics founded?

The earliest incorporation on record for SeLux Diagnostics, Inc. is in 2014, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences